Antipyrine metabolism in female Lewis and Dark Agouti strains of rats, which are extensive and poor metabolizers of debrisoquine, respectively.
- 1 January 1989
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 49 (3) , 433-435
- https://doi.org/10.1254/jjp.49.433
Abstract
The metabolism of antipyrine (AP) was investigated in female rats of the Dark Agouti (DA) and Lewis (L) strains, which have been proposed as models for human poor and extensive metabolizers of debrisoquine (DB), respectively. Following i.p. injection of 50 mg/kg of AP, the rate of production of 4-hydroxy-antipyrine in 24-hr urine was increased significantly in the L strain. The results suggested that different cytochrome P-450 isozymes were responsible for hydroxylation of AP and DB and showed interphenotype differences between the two strains.This publication has 4 references indexed in Scilit:
- SEX AND STRAIN DIFFERENCES IN HEPATIC DEBRISOQUINE 4-HYDROXYLASE ACTIVITY OF THE RAT1985
- Purification and characterization of the rat liver microsomal cytochrome P-450 involved in the 4-hydroxylation of debrisoquine, a prototype for genetic variation in oxidative drug metabolismBiochemistry, 1984
- Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4′-dihydroxy-antipyrineJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strainsJournal of Pharmacy and Pharmacology, 1981